Imran Talat Insider Trading Activity

Average Profitability
49.09%
Insider Buys Quantity
5
Insider Buys Sum
$106,499.24
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Imran Talat

According to the SEC Form 4 filings, Imran Talat, being in a position of

  1. Chief Executive Officer at Rani Therapeutics Holdings, Inc.,
    оver the last 12 months, has bought 35000 shares for $25,193, and sold 0 shares,
    over all time since 2023-11-07, has bought 85296 shares for $131,692, and sold 8014 shares for $11,300.

Biography of Imran Talat

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $25,1931100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-07-17PurchaseRani Therapeutics Holdings, Inc.
RANI
Chief Executive Officer
35,000
0.0553%
$0.72$25,193+14.3%
2024-12-27SaleRani Therapeutics Holdings, Inc.
RANI
Chief Executive Officer
8,014
0.0137%
$1.41$11,300-21.13%
2024-12-09PurchaseRani Therapeutics Holdings, Inc.
RANI
Chief Executive Officer
10,296
0.018%
$1.94$19,974-41.71%
2023-12-06PurchaseRani Therapeutics Holdings, Inc.
RANI
Chief Executive Officer
10,000
0.0173%
$2.27$22,700+30.75%
2023-12-04PurchaseRani Therapeutics Holdings, Inc.
RANI
Chief Executive Officer
5,000
0.0101%
$2.57$12,850+30.24%
2023-11-29PurchaseRani Therapeutics Holdings, Inc.
RANI
Chief Executive Officer
20,000
0.0409%
$2.05$41,000+68.97%
2023-11-07PurchaseRani Therapeutics Holdings, Inc.
RANI
Chief Executive Officer
5,000
0.0095%
$2.00$9,975+66.41%
Total: 7
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.